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Right ventricular failure in congenital heart disease
Young Kuk Cho, MD, Jae Sook Ma, MD
Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
Despite developments in surgical techniques and other interventions, right ventricular (RV) failure 
remains an important clinical problem in several congenital heart diseases (CHD). RV function is 
one of the most important predictors of mortality and morbidity in patients with CHD. RV failure is a 
progressive disorder that begins with myocardial injury or stress, neurohormonal activation, cytokine 
activation, altered gene expression, and ventricular remodeling. Pressure-overload RV failure caused 
by RV outflow tract obstruction after total correction of tetralogy of Fallot, pulmonary stenosis, atrial 
switch operation for transposition of the great arteries, congenitally corrected transposition of the great 
arteries, and systemic RV failure after the Fontan operation. Volume-overload RV failure may be caused 
by atrial septal defect, pulmonary regurgitation, or tricuspid regurgitation. Although the measurement 
of RV function is difficult because of many reasons, the right ventricle can be evaluated using both 
imaging and functional modalities. In clinical practice, echocardiography is the primary mode for the 
evaluation of RV structure and function. Cardiac magnetic resonance imaging is increasingly used for 
evaluating RV structure and function. A comprehensive evaluation of RV function may lead to early and 
optimal management of RV failure in patients with CHD.
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Introduction
Progress in new surgical techniques and medical management for congenital heart 
diseases (CHD) has dramatically improved patient survival over the past decades. How  ever, 
with many patients with CHD surviving until adulthood, right ventricular (RV) failure 
has become a concern
1). Several types of CHD are associated with RV failure, although 
surgical or interventional adjustments have been developed for CHD
1). RV outflow tract 
(RVOT) obstruction after total correction of the tetralogy of Fallot (TOF), pulmonary stenosis, 
atrial switch operation for transposition of the great arteries (TGA), congenitally corrected 
TGA (ccTGA), and systemic RV failure after the Fontan operation are the causes of 
pressure-overload RV failure
1,2). Another problem is the volume-overload RV failure 
that may be caused by atrial septal defect (ASD), pulmonary regurgitation, and tricuspid 
regurgitation
1,2). The development of RV failure associated with CHD should be carefully 
monitored, and both optimal medical and surgical treatments should be considered. The aim 
of this review is to provide an update on the current understanding of RV failure in patients 
with CHD. 
RV anatomy
In contrast to the ellipsoidal shape of the left ventricle (LV), in the sideward view, the right 
ventricle appears triangular, and in the cross-sectional view, it appears crescent shaped
3,4). The http://dx.doi.org/10.3345/kjp.2013.56.3.101
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right ventricle can be divided into 3 components: 1) the inlet, 2) the 
trabeculated apical myocardium, and 3) the infundibulum or conus
5) 
(Fig. 1). The specific morphological features of the anatomy of the 
right ventricle include the following: 1) the more apical attachment 
of the septal leaflet of the tricuspid valve relative to the anterior 
leaflet of the mitral valve, 2) the presence of a moderator band, 3) 
the presence of >3 papillary muscles, 4) the trileaflet of the tricuspid 
valve with septal papillary attachments, and 5) the presence of 
prominent and coarse trabeculations
3).
Although the right ventricle appears smaller than the LV in the 
4-chamber view, the volume of the right ventricle is more than that 
of the LV
4,6). In normal adults, RV mass is only approximately one-
sixth that of the LV, and the right ventricle has a wall thick  ness 3 
to 4 times less than that of the LV
7). Progressive regression of RV 
hypertrophy is observed as pulmonary vascular resistance (PVR) 
decreases during childhood
4). 
The right ventricle is linked to the LV at several points such 
as a shared ventricular septal wall, mutually encircling epicar-
dial fibers, attachment of the RV free wall to the anterior and 
posterior septum, and sharing the pericardial space
2).
RV physiology
The essential function of the right ventricle is to receive sys-
temic venous blood and pump it into the pulmonary arteries. 
In the absence of shunt physiology or significant valvular 
regurgitation, the right ventricle pumps the same stroke volume 
as the LV
4). However, the stroke work of the right ventricle is 
only approximately 25% of that of the LV because of low vascular 
resistance and pulmonary artery distensibility. Therefore, the 
right ventircle is thinner walled and more compliant
2-4) than 
the LV. RV contraction starts with the inlet and trabeculated 
myocardium and ends with the infundibulum
3). In contrast to the 
LV, twisting and rotational movements do not significantly contract 
the right ventricle, and RV shortening is greater longitu  dinally 
than radially
3,8). RV systolic function is a reflection of contractility, 
afterload, and preload. RV performance is also influenced by heart 
rhythm, synchrony of ventricular con  trac  tion, RV force-interval 
relationship, and ventricular interde  pendence
9-12). Compared with 
the LV, the right ventricle demon  strates a heightened sensitivity 
to afterload change
3,13,14). In clinical practice, PVR is the most 
commonly used index of afterload
3). The PVR is influenced by 
hypoxia or hypercarbia, cardiac output, pulmonary volume and 
pressure, and specific molecular pathways such as the nitric 
oxide, prostaglandin, and endothelin pathways
3,15,16). Excessive RV 
volume can com  press the LV and impair global LV function through 
the effects of ventricular interdependence
14). The main structures 
for ventricular interdependence include the ventricular septum, 
pericardium, and continuity between myocardial fibers of the right 
ventricle and LV
4). In acute RV pressure- or volume-overload states, 
dilatation of the right ventricle shifts the interventricular septum 
toward the left, altering LV geometry
3). This leads to a decreased LV 
preload, an increased LV end-diastolic pressure, or low cardiac 
output
12,15).
The pressure-overloaded right ventricle 
When the right ventricle is exposed to pressure overload, 
progressive dilation follows a primary adaptive response that 
includes hypertrophy
2). Although some reports state that hyper-
trophy itself is beneficial for overcoming the increased backward 
pressure, it is well accepted that a persistent increase in the 
pressure of the right ventricle causes a loss of contractile force that is 
required for pumping out the blood
17,18). Moreover, uncor  rected RV 
failure often induces diastolic dysfunction of the LV
2). Pressure 
overload of the right ventricle also may lead to RV ischemia, 
which may further aggravate ventricular dys  function
14). 
Compared with the volume-overload condition, histological 
changes are more common in the RV pressure-overload 
condition, in particular, increased myocardial fibrosis, which is seen 
in both animal and human studies
19,20). Two major conditions of 
pressure loading of the right ventricle are RVOT obstruction and 
the right ventricle supporting the systemic circulation. 
Isolated pulmonary stenosis is the most common RVOT ob-
structive CHD. Although the obstruction may also occur at the 
subvalvar or supravalvar levels, 80% to 90% of cases have valve 
level obstruction
1). Regardless of the level of obstruc  tion, the right 
ventricle exerts a hypertrophic response according to the degree 
of obstruction
21). The pressure gradient across the RVOT can be 
 
Fig. 1. Three-dimensional computed tomography images of a normal heart 
showing the inlet, trabeculated apical myocardium, and infundibulum of the 
right ventricle.103 http://dx.doi.org/10.3345/kjp.2013.56.3.101
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estimated by continuous wave Doppler echocardiography, which 
correlates well with catheter-based peak-to-peak gradient, obviating 
the need for cardiac catheterization
1,22).
In patients with moderate-to-severe pulmonary valve stenosis, 
symptoms are uncommon before adulthood
1). The right ventricle 
usually adapts well to pulmonary valve stenosis, even when the 
stenosis is severe. Longstanding untreated severe obstruction, 
however, may lead to RV failure and tricuspid regurgitation
1,4). 
Percutaneous valvuloplasty is considered in patients with 
moderate-to-severe pulmonary valve stenosis
4).
In terms of physiology and anatomy, the right ventricle has 
obvious disadvantages involved in supporting the systemic 
circulation. It is well suited to changes but is poorly tolerant to acute 
changes in afterload
1,7). Late RV failure usually occurs in patients 
with TGA who have undergone an atrial switch surgery and in 
patients with ccTGA, because the anatomy of the right ventricle 
supports the systemic circulation
1,23). The cause of RV dysfunction 
is unclear. However, myocardial perf  usion defects, uncoordinated 
myocardial contraction, and systemic atrioventricular valve 
(tricuspid valve) regurgitation contribute to the progressive decline 
in RV function in patients who have undergone an atrial switch 
operation
1,23,24). RV dilata  tion and impaired systolic function 
correlates inversely with RV systolic function
25).
In patients with ccTGA, long-term outcome is abnormal even in 
patients without associated lesions. Moderate-to-severe sys  temic 
atrioventricular valve (tricuspid valve) regurgitation and RV failure 
are associated with increased mortality
1,4,26). RV dysfunction usually 
starts within 5 years from the onset of TR in ccTGA patients without 
associated lesions
2). RV failure with ventricular enlargement also 
results in TR aggravation due to annular dilatation. Tricuspid valve 
replacement may slow the progression of RV failure
18). Among the 
older patients with ccTGA, many may be considered for mechanical 
support or heart trans  plantation
3).
The volume-overloaded right ventricle
The right ventricle adapts better to volume overload than to 
pressure overload
18) and may tolerate volume overload for a long 
time without significant systolic dysfunction
1). Recent studies, 
however, have demonstrated that chronic volume overload is 
associated with increased morbidity and mortality
1).
A large ASD results in left-to-right shunting and volume 
over  load of the right ventricle
18). Large ASDs may remain mi-
nimally symptomatic during the high-volume phase, until 
and Eisenmenger’s syndrome and pulmonary vasculopathy 
develop
2). In contrast to patients with ventricular septal defects, only 
a small percentage of patients with ASD develop Eisen  menger’s 
syndrome in later life
27). Age older than 40 years at closure is 
associated with incomplete right ventricle, right atrial reverse 
remodeling, and increased risk of arrhythmias
1,27). Closure of the 
ASD is contraindicated in patients with Eisenmenger physiology, 
unless significant regression of pulmonary vascular disease occurs 
with pharmacological therapy
3).
Severe pulmonary regurgitation is the most common cause 
of progressive RV dilatation and dysfunction in patients with 
repaired TOF
1). It is associated with decreased exercise tolerance, 
arrhythmias, and sudden death
1). Severe and progressive RV dila-
tation may be a primary sign of a RV dysfunction, an indica  tion 
for pulmonary valve replacement. Pulmonary valve replacement 
generally results in ventricular reverse re  modeling with a 
decrease in RV volume
1). Advanced severe RV dilatation with an 
end-diastolic volume >170 mL/m
2 or an end-systolic volume >85 
mL/m
2 before replacement, however, is associated with persistence 
of RV dilatation after surgery
28). In TOF, a “restrictive RV phy-
siology” has been associated with worse outcome after repair of 
TOF
1). A restrictive RV physio  logy is characterized by the presence 
of forward and laminar late diastolic pulmonary flow throughout 
respiration
1). Early after TOF repair, restrictive RV physiology is 
associated with a low cardiac output and longer intensive care unit 
stay
1,29). Late after TOF repair, however, restrictive RV physiology 
counteracts the effects of chronic pulmonary regurgitation
1,30).
Ebstein anomaly is characterized by an apical displacement 
of the septal and posterior tricuspid leaflets exceeding 8 mm/m
2 
1,31), leading to an atrialized RV and moderate-to-severe tricuspid 
regurgitation. RV failure in Ebstein anomaly results from volume 
overload of the right ventricle and from a hypoplastic RV 
chamber unable to manage the systemic venous blood
18). In 
symptomatic patients, the size of the functional RV and tricuspid 
valve morphology determine the best surgical technique
1). 
Assessment of the right ventricle
Although the measurement of RV function is difficult, the 
right ventricle can be evaluated using several imaging and 
functional modalities
2,18). In clinical practice, echocardiography is 
the mainstay for evaluating the RV structure and function
18). 
Compared with other modalities, it is versatile and available 
at all institutes
18). In addition, Doppler-derived indices such as 
the myocardial performance index (MPI) and tricuspid annular 
isovolumic acceleration (IVA) are emerging as promising 
parameters of RV function
18). Cardiac magnetic resonance 
imaging (MRI) is the primary technique for evaluating RV 
structure and function
18). MRI is considered the most accurate 
tool for assessing RV volume
18). MRI may have an extending 
future role in assessing the physiological characteristics of 
pulmonary arterial flow
18). Radionuclide-based techniques 
provide reliable and geometrically independent assessments of 
RV ejection fraction (RVEF)
18). Radionuclide based time activity http://dx.doi.org/10.3345/kjp.2013.56.3.101
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curves are also useful in the quantification of shunts
16). Cardiac 
catheterization provides direct hemodynamic data and allows 
accurate assessment of PVR. Pulmonary angiography and 
coronary angiography can further delineate important anato-
mic and functional characteristics
18). The simplest method for 
assessing RV volume includes linear dimensions and areas 
obtained from single tomographic echocardiographic planes
18). 
In an effort to be more accurate, different approaches have 
been sought to measure RV volume. These include the area-length 
method and the Simpson’s rule method
18). Three-dimen  sional 
echocardiography is a promising technique that could lead to 
more accurate measurement of RV volume
18).
The study of RV function comprises indices that reflect RV 
systolic function, RV diastolic function, and valvular func  tion 
2,32). The most commonly used echocardiographic indices of RV 
systolic function are as follows: 1) geometric indices such as 
RV fractional area change, RVEF, and tricuspid annular plane 
systolic excursion (Fig. 2), which reflect the extent of contraction; 
2) myocardial velocity indices such as the tricuspid annular 
plane maximal systolic velocity and the IVA (Fig. 3); 3) hemo-
dynamic indices such as the first RV derivative of pressure and 
time (RV dP/dt); and 4) time interval indices such as the RV MPI 
(Fig. 4) or Tei index, which reflect both systolic and diastolic 
parameters
33). Right atrial pressure (RAP) is a clini  cally useful 
diastolic variable of RV diastolic function
34). In patients who are 
not being mechanically ventilated, the inferior vena cava size and 
collapse index correlate well with RAP
4). Recent studies showed 
that serum levels of B-type natriuretic peptide may be useful 
in diagnosing RV failure associated with CHD
35,36). Elevated 
troponin levels have also been associated with worse outcomes 
in pulmonary embolism and pulmonary hypertension
37,38). 
Management of RV failure 
For the management of RV failure, the cause and setting of 
the failure should be considered
18). The ultimate treatment goals 
include optimization of preload, afterload, and contractility
18). 
Maintenance of sinus rhythm and atrioventricular synchrony 
Fig. 2. Measurements of the tricuspid annular plane systolic excursion (TAPSE) 
using M-mode echocardiography at the junction of the tricuspid valve plane 
with the free wall of the right ventricle.
 
Fig. 3. Measurement of isovolumic acceleration (IVA) during isovolumic 
contraction at the level of the tricuspid annulus using a tissue Doppler echo-
cardiography spectral curve. IVV, peak isovolumic velocity; t, time from zero 
crossing to peak isovolumic velocity. IVA=IVV/t.
 
Fig. 4. Measurement of right ventricular (RV) myocardial performance index (MPI) using pulsed-wave Doppler at the tip of 
tricuspid leaflets in the apical 4-chamber view (A) and at the site of just below the pulmonary valve in the RV outflow tract 
view (B). E, rapid filling velocity; A, atrial filling velocity; a, sum of isovolumic contraction time (IVCT), isovolumic relaxation 
time (IVRT) and ejection time (ET). RV MPI=(IVRT+IVCT)/ET=(a-ET)/ET.105 http://dx.doi.org/10.3345/kjp.2013.56.3.101
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is especially important in RV failure because atrial fibrillation 
and atrioventricular block may have profound hemodynamic 
effects
18). In patients with RV dysfunction and valvular heart 
disease or CHD, corrective surgery or percutaneous interven  tion 
should be considered in suitable candidates
18,39,40). Clinically, the 
assessment of optimal preload in RV failure remains challen-
ging
18). If no hemodynamic improvement is observed with an 
initial fluid challenge of normal saline, volume loading should 
not be continued
18). The hemodynamic improvement seen 
with nitric oxide is most likely secondary to selective pulmo-
nary vasodilatation, resulting in a reduction in RV afterload 
and subsequent improvement in RV performance
41). Acute 
responsiveness to pulmonary vasodilators is associated with 
a better prognosis and survival in patients with advanced 
heart failure
42,43). In patients with acute hemodynamically 
compromising RV failure, inotropic or vasopressor support may 
be required
18). Dobutamine is the most commonly used inotrope 
in cases of RV failure
44). In patients with pulmonary hypertension, 
dobutamine at doses of 2–5 μg · kg
-1
 · min
-1 in  creases cardiac 
output but decreases PVR
44). The combination of dobutamine 
and nitric oxide in patients with pulmonary hypertension also 
has been shown to be beneficial
44). Dopamine is used in severely 
hypotensive patients, whereas milrinone is preferred in the 
presence of tachyarrhythmias induced by dopamine or in patients 
on β-blockers
18). Digoxin therapy for RV failure has been studied 
in pulmonary hypertension and chronic pulmonary disease
18). 
Maintenance of sinus rhythm and heart rate control are important 
in RV failure. High-degree AV block or atrial fibrillation may 
have profound hemodynamic consequences
18). The RVEF in 
patients with either systemic or pulmonic RV was improved by 
cardiac resynchronization therapy
45). The effects of β-blockade 
and angiotensin-converting enzyme inhibition have been studied 
mainly in LV heart failure. In patients with biventricular failure, 
angiotensin-converting enzyme inhibition has been shown 
to increase RVEF and to reduce RV end-diastolic volume and 
filling pressures
46). Small studies also have demonstrated that 
β-blockade with carvedilol or bisoprolol improves RV systolic 
function
47). Clinical studies that assessed the role of angiotensin- 
converting enzyme inhibitors or angiotensin receptor blockers 
in the systemic right ventricle found that they do not improve 
exercise capacity or hemodynamics, although those studies may 
have been underpowered
48). In patients with acute RV failure 
that is refractory to medical treatment, mechanical support 
with an right ventricle assisting device may be used as a bridge 
to transplantation or recovery
18). The development of new 
therapeutic strategies for RV failure is warranted. These new 
strategies might include cell-based or gene therapies, new drugs, 
or new combinations of existing drugs
2). 
Conclusions
RV failure remains an important cause of morbidity and 
mortality in patients with CHD both before and after cardiac 
surgery or intervention. Although recent advances in imaging 
including cardiac MRI, echocardiography remains pivotal for the 
noninvasive assessment of the right ventricle. A com  prehensive 
evaluation of RV function may improve risk assess  ment and lead 
to early and optimal management of RV failure in patients with 
CHD.
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